Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis [Phase 4]
Phase 4 trial assessing whether infliximab induces histologic and endoscopic remission in moderate to severe ulcerative colitis; study statu…
-
FDA approval · 2012-12-12FDA Approved: AZULFIDINE EN-TABS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Azulfidine En-Tabs (sulfasalazine) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS research · 2012-12-10Clinical Trial Update: Colon Capsule Endoscopy Versus Standard Colonoscopy in Ulcerative Colitis
A clinical trial comparing colon capsule endoscopy to standard colonoscopy in ulcerative colitis was terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC) [Phase 4]
Phase 4 clinical trial evaluating leukocytapheresis for ulcerative colitis was terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 3]
This update reports results from a Phase 3 study of adalimumab in Japanese patients with moderately to severely active ulcerative colitis, w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-11-13FDA Approved: BALSALAZIDE DISODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for balsalazide disodium from Hikma Pharmaceuticals USA Inc., confirming continued approval for the …
-
CLINICAL_TRIALS research · 2012-11-05Clinical Trial Update: Photodynamic Therapy for Ulcerative Colitis [Phase 1]
A Phase 1 clinical trial is evaluating photodynamic therapy for ulcerative colitis; the trial status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis [Phase 3]
An update on a Phase 3 trial assessing the efficacy and safety of adalimumab for inducing clinical response in ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Thalidomide in Pediatric Inflammatory Bowel Diseases. [Phase 3]
Phase 3 pediatric trial of thalidomide for inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis [Phase 3]
Phase 3 clinical trial update for Home Telemanagement (UC HAT) in ulcerative colitis has completed with results posted in 2012.
-
FDA approval · 2012-10-03FDA Approved: SULFASALAZINE — Supplemental Application (Sunrise Pharmaceutical, Inc.)
The FDA approved a supplemental application for sulfasalazine from Sunrise Pharmaceutical, Inc., marking an approval action for this generic…
-
FDA approval · 2012-09-28FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2012-08-01FDA Approved: MERCAPTOPURINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Mercaptopurine from Hikma Pharmaceuticals USA Inc., supporting the generic product under AND…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Open-Label Adalimumab for Ulcerative Colitis Patients [Phase 1]
An open-label Phase 1 trial evaluated adalimumab in patients with ulcerative colitis. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis [Phase 1]
Phase 1 trial assessing safety and tolerability of a single dose of ASP3291 in adults with Ulcerative Colitis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC) [Phase 3]
Phase 3 trial comparing budesonide capsules to mesalazine granules in active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC) [Phase 3]
Phase 3 trial comparing once-daily versus three-times-daily dosing of mesalazine granules for prevention of Ulcerative Colitis recurrence ha…
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis [Phase 3]
A Phase 3 trial in children and adolescents evaluating maintenance therapy with Asacol (mesalamine) for Ulcerative Colitis was terminated, w…
-
FDA approval · 2012-05-24FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis [Phase 3]
Phase 3 trial completed evaluating the safety and effectiveness of a new medication for active Ulcerative Colitis.
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis [Phase 3]
The update reports the completion of a Phase 3 trial (FACTS II) evaluating a new medication for active Ulcerative Colitis. The study lists O…
-
FDA approval · 2012-05-02FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab (Stelara) from Janssen Biotech, Inc., resulting in a labeling change/addition.
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC) [Phase 2]
The Phase 2 study of visilizumab for intravenous steroid-refractory ulcerative colitis has been terminated.
-
CLINICAL_TRIALS withdrawal · 2012-04-23Clinical Trial Update: Cerebral Resonance Magnetic Imaging During Rectal Distention
The trial NCT00213330 sponsored by University Hospital Rouen has been withdrawn. It studied cerebral resonance magnetic imaging during recta…
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis [Phase 4]
Phase 4 clinical trial evaluating changes in apoptosis regulators after stopping 5-aminosalicylic acid treatment in inactive ulcerative coli…